Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa

This publication has 12 references indexed in Scilit:

• Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia
  American Journal of Respiratory and Critical Care Medicine, 2005
• Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa
  Clinical Infectious Diseases, 2003
• Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
  Critical Care, 2003
• Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP
  Clinical Infectious Diseases, 2003
• Resistance Patterns Among Nosocomial Pathogens
  Chest, 2001
• Treatment of Nosocomial Pneumonia and Tracheobronchitis Caused by Multidrug-Resistant Pseudomonas aeruginosa with Aerosolized Colistin
  American Journal of Respiratory and Critical Care Medicine, 2000
• Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units
  American Journal of Infection Control, 2000
• Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii
  Clinical Infectious Diseases, 1999
• Evaluation of New Anti-Infective Drugs for the Treatment of Respiratory Tract Infections
  Clinical Infectious Diseases, 1992
• Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
  Journal of Antimicrobial Chemotherapy, 1987